GSS EU Science Funding Gateway

Τhe partnership should address the following objectives:

• Putting Europe at the forefront of research and innovation through the support of multidisciplinary actions open to international cooperation;
• Establishing a European national and regional network of research and innovation systems dedicated to personalised medicine;
• Translating basic research into clinical applications that make a difference for patients, their families and healthcare professionals;
• Filling scientific knowledge gaps, producing evidence and developing guidance and tools in priority areas for the development and the deployment of personalised medicine;
• Integrating big data and digital health solutions in research and personalised healthcare;
• Strengthening the European healthcare industry and accelerating the uptake of personalised medicine solutions;
• Developing appropriate ecosystems for the implementation of successful personalised medicine approaches and a swift uptake of relevant innovations by healthcare systems;
• Providing socio-economic evidence of the feasibility of personalised medicine approaches for its uptake by sustainable healthcare systems;
• Improving health outcomes for citizen and patients and ensuring a wide access to advanced personalised medicine intervention approaches to all.

The Partnership’s governance structure should enable an upfront strategic steering, effective management and coordination, daily implementation of activities and ensure the use and uptake of the results. The governance should leave sufficient space for involving the key stakeholders, including but not limited to R&I community, patients and citizens, healthcare professionals, formal and informal care organisations, and innovation owners.

Beneficiaries – may provide financial support to third parties. The support to third parties can only be provided in the form of grants. Financial support provided by the participants to third parties is one of the primary activities of the action in order to be able to achieve its objectives. Given the type of action and its level of ambition, the maximum amount to be granted to each third party is €10,00 million.